Literature DB >> 29703762

New links between lipid accumulation and cancer progression.

Joseph T Nickels1,2.   

Abstract

Individuals with elevated lipid levels are at risk for developing cardiovascular disease as well as cancer. Sterol regulatory element-binding protein transcription factors (SREBPs) are inducers of lipid synthesis. Elevated SREBPs levels are linked to cell proliferation and metastasis. Using biochemical and mouse models of cancer, Zhao et al. have discovered that nuclear SREBP-1a-dependent transcription is activated by pyruvate kinase M2 in cancer cells, which promotes tumor growth. Targeting the lipogenesis pathway may therefore be a promising avenue for cancer treatment.
© 2018 Nickels.

Entities:  

Keywords:  cancer; cell proliferation; cholesterol metabolism; dyslipidemia; sterol regulatory element-binding protein; tumor cell biology; tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 29703762      PMCID: PMC5925807          DOI: 10.1074/jbc.H118.002654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans.

Authors:  M S Brown; J Ye; R B Rawson; J L Goldstein
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.

Authors:  M Matsuda; B S Korn; R E Hammer; Y A Moon; R Komuro; J D Horton; J L Goldstein; M S Brown; I Shimomura
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

Review 3.  Regulation of the SREBP transcription factors by mTORC1.

Authors:  Caroline A Lewis; Beatrice Griffiths; Claudio R Santos; Mario Pende; Almut Schulze
Journal:  Biochem Soc Trans       Date:  2011-04       Impact factor: 5.407

4.  Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.

Authors:  Xiaoping Zhao; Li Zhao; Hao Yang; Jiajin Li; Xuejie Min; Fajun Yang; Jianjun Liu; Gang Huang
Journal:  J Biol Chem       Date:  2018-03-07       Impact factor: 5.157

5.  Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques.

Authors:  Jing-Jie Tang; Jia-Gui Li; Wei Qi; Wen-Wei Qiu; Pei-Shan Li; Bo-Liang Li; Bao-Liang Song
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

Review 6.  SREBPs: the crossroads of physiological and pathological lipid homeostasis.

Authors:  Rajendra Raghow; Chandrahasa Yellaturu; Xiong Deng; Edwards A Park; Marshall B Elam
Journal:  Trends Endocrinol Metab       Date:  2008-03       Impact factor: 12.015

7.  A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.

Authors:  Shinji Kamisuki; Qian Mao; Lutfi Abu-Elheiga; Ziwei Gu; Akira Kugimiya; Youngjoo Kwon; Tokuyuki Shinohara; Yoshinori Kawazoe; Shin-ichi Sato; Koko Asakura; Hea-Young Park Choo; Juro Sakai; Salih J Wakil; Motonari Uesugi
Journal:  Chem Biol       Date:  2009-08-28

8.  Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N).

Authors:  B S Korn; I Shimomura; Y Bashmakov; R E Hammer; J D Horton; J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

Review 9.  Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.

Authors:  Upasana Ray; Sib Sankar Roy
Journal:  FEBS J       Date:  2017-10-23       Impact factor: 5.542

  9 in total
  8 in total

1.  Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma.

Authors:  Mankun Wei; Uli Nurjanah; Arin Herkilini; Can Huang; Yanjun Li; Makoto Miyagishi; Shourong Wu; Vivi Kasim
Journal:  Cell Mol Life Sci       Date:  2022-08-06       Impact factor: 9.207

2.  FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.

Authors:  Chunyu Zhang; Yuandong Liao; Pan Liu; Qiqiao Du; Yanchun Liang; Shiyin Ooi; Shuhang Qin; Shanyang He; Shuzhong Yao; Wei Wang
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

Review 3.  The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.

Authors:  Borja Guerra; Carlota Recio; Haidée Aranda-Tavío; Miguel Guerra-Rodríguez; José M García-Castellano; Leandro Fernández-Pérez
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

4.  Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.

Authors:  Mingjun Zheng; Heather Mullikin; Anna Hester; Bastian Czogalla; Helene Heidegger; Theresa Vilsmaier; Aurelia Vattai; Anca Chelariu-Raicu; Udo Jeschke; Fabian Trillsch; Sven Mahner; Till Kaltofen
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

5.  Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas.

Authors:  Liguo Ye; Yang Xu; Long Wang; Chunyu Zhang; Ping Hu; Shi'ao Tong; Zhennan Liu; Daofeng Tian
Journal:  Cancer Med       Date:  2021-10-06       Impact factor: 4.452

Review 6.  Lipid Metabolism and Cancer.

Authors:  Hui Cheng; Meng Wang; Jingjing Su; Yueyue Li; Jiao Long; Jing Chu; Xinyu Wan; Yu Cao; Qinglin Li
Journal:  Life (Basel)       Date:  2022-05-25

7.  Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer.

Authors:  Nan Wang; Xuanyu Huang; Qian Long
Journal:  J Inflamm Res       Date:  2022-09-05

Review 8.  Signaling networks in immunometabolism.

Authors:  Jordy Saravia; Jana L Raynor; Nicole M Chapman; Seon Ah Lim; Hongbo Chi
Journal:  Cell Res       Date:  2020-03-20       Impact factor: 25.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.